Vascular risk factors, large-artery atheroma, and brain white matter hyperintensities

Neurology

Volumn 82, Issue 15, 2014, Pages 1331-1338

  Wardlaw, Joanna M ^a   Allerhand, Michael ^b   Doubal, Fergus N ^a   Hernandez, Maria Valdes ^a,b   Morris, Zoe ^a   Gow, Alan J ^b   Bastin, Mark ^a,b   Starr, John M ^b   Dennis, Martin S ^a   Deary, Ian J ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; ATHEROMA; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; FEMALE; HUMAN; HYPERTENSION; LEG; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; STROKE PATIENT; WHITE MATTER; ARTERY; ATHEROSCLEROTIC PLAQUE; BRAIN; DEMENTIA; MIDDLE AGED; MYELINATED NERVE; PATHOLOGY; RISK FACTOR; VASCULAR DISEASE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ARTERIES; BRAIN; DEMENTIA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE FIBERS, MYELINATED; PLAQUE, ATHEROSCLEROTIC; RISK FACTORS; VASCULAR DISEASES;

EID: 84902113318     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000312     Document Type: Article

References (39)

1. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010; 341: c3666.
2. Baezner H, Blahak C, Poggesi A, et al. Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology 2008; 70: 935-942. (Pubitemid 351430742)
3. Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroi-maging. Lancet Neurol 2013; 12: 483-497.
4. Marcus J, Gardener H, Rundek T, et al. Baseline and longitudinal increases in diastolic blood pressure are associated with greater white matter hyperintensity volume: the Northern Manhattan Study. Stroke 2011; 42: 2639-2641.
5. Guo X, Pantoni L, Simoni M, et al. Blood pressure components and changes in relation to white matter lesions: a 32-year prospective population study. Hypertension 2009; 54: 57-62.
6. Dufouil C, De Kersaint-Gilly A, Besancon V, et al. Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort. Neurology 2001; 56: 921-926. (Pubitemid 32290809)
7. de Leeuw FE, de Groot JC, Oudkerk M, et al. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 2002; 125: 765-772. (Pubitemid 34279772)
8. Gottesman RF, Coresh J, Catellier DJ, et al. Blood pressure and white-matter disease progression in a biethnic cohort. Atherosclerosis Risk in Communities (ARIC) Study. Stroke 2010; 41: 3-8.
9. Godin O, Tzourio C, Maillard P, Mazoyer B, Dufouil C. Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the Three-City (3C)-Dijon Magnetic Resonance Imaging Study. Circulation 2011; 123: 266-273.
10. de Leeuw FE, de Groot JC, Bots ML, et al. Carotid atherosclerosis and cerebral white matter lesions in a population based magnetic resonance imaging study. J Neurol 2000; 247: 291-296. (Pubitemid 30223967)
11. Dufouil C, Chalmers J, Coskun O, et al. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation 2005; 112: 1644-1650. (Pubitemid 41324527)
12. Weber R, Weimar C, Blatchford J, et al. Telmisartan on top of antihypertensive treatment does not prevent progression of cerebral white matter lesions in the prevention regimen for effectively avoiding second strokes (PRoFESS) MRI substudy. Stroke 2012; 43: 2336-2342.
13. Benavente OR, McClure LA, Coffey CS, et al. The secondary prevention of small subcortical strokes (SPS3) Trial: results of the blood pressure intervention. Lancet 2013; 382: 507-515.
14. Liu W, Liu R, Sun W, et al. Different impacts of blood pressure variability on the progression of cerebral microbleeds and white matter lesions. Stroke 2012; 43: 2916-2922.
15. Rost NS, Rahman R, Sonni S, et al. Determinants of white matter hyperintensity volume in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis 2010; 19: 230-235.
16. Gouw AA, van der Flier WM, Fazekas F, et al. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability Study. Stroke 2008; 39: 1414-1420.
17. Wardlaw JM, Doubal FN, Valdes-Hernandez MC, et al. Blood-brain barrier permeability and long term clinical and imaging outcomes in cerebral small vessel disease. Stroke 2013; 44: 525-527.
18. ten Dam VH, van den Heuvel DM, van Buchem MA, et al. Effect of pravastatin on cerebral infarcts and white matter lesions. Neurology 2005; 64: 1807-1809. (Pubitemid 40695828)
19. SPS3 Investigators. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med 2012; 367: 817-825.
20. Palacio S, Hart RG, Pearce LA, Benavente OR. Effect of addition of clopidogrel to aspirin on mortality: systematic review of randomized trials. Stroke 2012; 43: 2157-2162.
21. Deary IJ, Gow AJ, Taylor MD, et al. The Lothian Birth Cohort 1936: a study to examine influences on cognitive ageing from age 11 to age 70 and beyond. BMC Geriatr 2007; 7: 28.
22. Doubal FN, MacGillivray TJ, Hokke PE, Dhillon B, Dennis MS, Wardlaw JM. Differences in retinal vessels support a distinct vasculopathy causing lacunar stroke. Neurology 2009; 72: 1773-1778.
23. Wardlaw JM, Bastin ME, Valdes Hernandez MC, et al. Brain aging, cognition in youth and old age and vascular disease in the Lothian Birth Cohort 1936: rationale, design and methodology of the imaging protocol. Int J Stroke 2011; 6: 547-559.
24. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007; 115: 459-467. (Pubitemid 46184197)
25. Wardlaw JM, Lewis S. Carotid stenosis measurement on colour Doppler ultrasound: agreement of ECST, NASCET and CCA methods applied to ultrasound with intra-arterial angiographic stenosis measurement. Eur J Radiol 2005; 56: 205-211. (Pubitemid 41483020)
26. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987; 149: 351-356. (Pubitemid 17104996)
27. Valdes Hernandez MC, Ferguson KJ, Chappell FM, Wardlaw JM. New multispectral MRI data fusion technique for white matter lesion segmentation: method and comparison with thresholding in FLAIR images. Eur Radiol 2010; 20: 1684-1691.
28. Wang X, Valdes Hernandez MC, Doubal F, Chappell FM, Wardlaw JM. How much do focal infarcts distort white matter lesions and global cerebral atrophy measures? Cerebrovasc Dis 2012; 34: 336-342.
29. Fox J, Weisberg S. An R Companion to Applied Regression, 2nd ed. Thousand Oaks: Sage Publications; 2011.
30. Child D. The Essentials of Factor Analysis, 3rd ed. London: Continuum International Publishing Group; 2006.
31. Muthén LK, Muthén BO. Mplus User's Guide, 6th ed. Los Angeles: Muthén & Muthén; 2010.
32. Preacher KJ, Hayes AF. SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Methods Instrum Comput 2004; 36: 717-731. (Pubitemid 40251423)
33. Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 2008; 40: 879-891.
34. O'Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE Study): a case-control study. Lancet 2010; 376: 112-123.
35. van Dijk EJ, Breteler MMB, Schmidt R, et al. The association between blood pressure, hypertension, and cerebral white matter lesions: Cardiovascular Determinants of Dementia Study. Hypertension 2004; 44: 625-630. (Pubitemid 39435230)
36. van Dijk EJ, Prins ND, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MM. Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan Study. Stroke 2008; 39: 2712-2719.
37. Glymour MM, Weuve J, Berkman LF, Kawachi I, Robins JM. When is baseline adjustment useful in analyses of change? An example with education and cognitive change. Am J Epidemiol 2005; 162: 267-278.
38. Wills AK, Lawlor DA, Matthews FE, et al. Life course trajectories of systolic blood pressure using longitudinal data from eight UK cohorts. PLoS Med 2011; 8: e1000440.
39. Cavalieri M, Schmidt R, Chen C, et al. B vitamins and magnetic resonance imaging-detected ischemic brain lesions in patients with recent transient ischemic attack or stroke: the VITAmins TO Prevent Stroke (VITATOPS) MRI-substudy. Stroke 2012; 43: 3266-3270.